Welcome to our dedicated page for Grayscale Basic Attention Token Trust (BAT) SEC filings (Ticker: GBAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Grayscale Basic Attention Token Trust (BAT)'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Grayscale Basic Attention Token Trust (BAT)'s regulatory disclosures and financial reporting.
GBAT filed a Form 144 notice for the proposed sale of 2,250 common shares. The filing lists an aggregate market value of $4,545, with an approximate sale date of 11/06/2025 through Canaccord Genuity Corp on the OTCQB.
The seller acquired these shares on 02/27/2021 in a privately negotiated purchase from the issuer for cash. Shares outstanding were 2,842,800; this is a baseline figure, not the amount being sold.
Recent Rule 144 activity shows multiple sales in the past three months, including 2,500 shares on 08/06/2025 for $3,500 and 2,200 shares on 11/05/2025 for $4,642.
GBAT filed a Form 144 notice for a proposed sale of 2,200 common shares with an aggregate market value of $4,642. The filing lists Canaccord Genuity Corp. as broker and identifies the trading venue as OTCQB, with an approximate sale date of 11/05/2025. The table shows 2,842,800 shares outstanding.
The shares to be sold were acquired on 02/27/2021 in a privately negotiated transaction, purchased from the issuer for cash. The recent activity table also lists multiple past sales by DCG International Investments Ltd., including 2,200 shares on 11/04/2025 for $4,466 and 2,250 shares on 10/31/2025 for $2,700.
GBAT: A selling stockholder filed a Form 144 notice to sell 2,200 common shares with an aggregate market value of $4,466.00. The planned sale is through Canaccord Genuity Corp on the OTCQB, with an approximate sale date of 11/04/2025.
Shares outstanding were 2,842,800. Over the past three months, the filer reported multiple open‑market sales, including 2,200 shares on 10/30/2025 for $2,706.00 and 2,500 shares on 08/04/2025 for $3,500.00.
DCG International Investments Ltd. filed a Form 144 notice to sell 2,200 common shares of GBAT. The filing lists an aggregate market value of $3,212.00 for the planned sale, with an approximate sale date of 11/03/2025 on the OTCQB. The broker named is Canaccord Genuity Corp (Vancouver).
The shares to be sold were acquired on 06/24/2021 in a privately negotiated transaction from the issuer for cash. As context, the filing states 2,842,800 shares outstanding. The notice also lists recent sales by the same holder over the last three months, including 2,500 shares on 08/05/2025 (gross proceeds $3,400.0) and 2,200 shares on 10/28/2025 (gross proceeds $3,344.0).
GBAT reported a Form 144 notice for a proposed sale of 2,250 common shares through Canaccord Genuity Corp on the OTCQB, with an approximate sale date of 10/31/2025. The filing lists an aggregate market value of 2700.00 for the planned shares. Shares outstanding were 2,842,800, which is a baseline figure and not the amount being sold.
The shares to be sold were acquired on 06/24/2021 in a Privately Negotiated Transaction, purchased from the issuer and paid in cash on the same date. The notice also discloses recent sales over the past three months by DCG International Investments Ltd, including 2,500 shares on 08/05/2025 for 3400.0 and 2,200 shares on 10/30/2025 for 2706.0.
GBAT filed a Form 144 notice for a proposed sale of 2,200 common shares through Canaccord Genuity Corp on the OTCQB, with an approximate sale date of 10/30/2025 and an aggregate market value of $2,706.00. The shares were acquired on 06/24/2021 via a privately negotiated purchase from the issuer for cash.
As context, 2,842,800 shares were outstanding. The filer also reported multiple recent sales in the past three months, including transactions on 07/30/2025, 08/05/2025, and 10/29/2025.
GBAT — A shareholder filed a Form 144 notice to sell 2,200 common shares. The filing lists an aggregate market value of 3,344.00, an approximate sale date of 10/28/2025, and identifies Canaccord Genuity Corp as broker, with sales on the OTCQB.
The notice states 2,842,800 shares outstanding. It also discloses prior sales by DCG International Investments Ltd during the past three months, including 2,300 shares on 07/30/2025 for gross proceeds of 3588.0 and 2,500 shares on 08/05/2025 for 3400.0.
DCG International Investments Ltd filed a Form 144 notice to sell 2,200 shares of GBAT common stock through Canaccord Genuity Corp. The filing lists an aggregate market value of $3,432.00, an approximate sale date of 10/27/2025, and the trading venue as OTCQB.
The securities were acquired on 06/24/2021 in a privately negotiated transaction, purchased from the issuer for cash. The filing notes 2,842,800 shares outstanding; this is a baseline figure, not the amount being sold.
Recent reported sales by the same seller over the past three months include examples such as 2,300 shares on 07/30/2025 for $3,588.0 and 2,500 shares on 08/05/2025 for $3,400.0.
GBAT filed a Form 144 notice indicating an intent to sell 2,200 common shares, with an aggregate market value of $3,285.92. The filing lists Canaccord Genuity Corp as broker, with sales expected on or about October 24, 2025 on the OTCQB.
The seller acquired the 2,200 shares on June 24, 2021 in a privately negotiated transaction from the issuer, paid in cash. The notice also reports prior sales in the last three months, including 2,500 shares on August 6, 2025 for $3,500.00 and 2,400 shares on July 29, 2025 for $3,768.00. Shares outstanding were 2,842,800 at the time indicated in the notice.